IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding IDEAYA Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 89 | 84 | −5 |
| Shares | 23.8M | 25.4M | +1.63M (+6.9%) |
| Value | $558.6M | $533.4M | −$25.2M (−4.5%) |
New holders (7)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AXA S.A. | 240,107 | $5.04M | 0.01% |
| ACT Capital Management, LLC | 69,200 | $1.45M | 0.75% |
| Mesirow Financial Investment Management, Inc. | 20,084 | $422.0K | 1.08% |
| Voya Investment Management LLC | 11,049 | $232.0K | 0.00% |
| Virtus ETF Advisers LLC | 10,177 | $214.0K | 0.09% |
| Quantbot Technologies LP | 400 | $8.00K | 0.00% |
| Group One Trading, L.P. | 300 | $6.00K | 0.00% |
Sold out (12)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| BVF Inc | 2,607,969 | $61.3M |
| Marshall Wace North America L.P. | 167,571 | $3.94M |
| Pura Vida Investments, LLC | 60,744 | $1.43M |
| California Public Employees Retirement System | 32,400 | $761.0K |
| Squarepoint Ops LLC | 23,740 | $558.0K |
| D. E. Shaw & Co., Inc. | 19,293 | $453.0K |
| Susquehanna International Group, LLP | 10,739 | $252.0K |
| Marshall Wace, LLP | 10,160 | $239.0K |
| AlphaCentric Advisors LLC | 10,000 | $235.0K |
| Point72 Hong Kong Ltd | 538 | $13.0K |
| Tradewinds Capital Management, LLC | 500 | $12.0K |
| Bank of Montreal | 525 | $11.0K |